retatrutide weight loss phase 2 results trial data Looking forward to when # retatrutide's 3 will become available Retatrutide: A Promising Option for – Retatrutide Shows Promising Weight Loss

The Bottom Line Both TRT and GHS peptides can improve muscle mass, bone density, body composition, and lipid profiles, all of which decline with age

Chips, protein shakes, coffee, and alcohol rounded out the top five most-craved items

Clinically proven approach Doctor prescribed & medically supervised Personalized dosing for optimal results Ongoing support from our care team *These statements have not been evaluated by the Food and Drug Administration

Another triple agonist candidate, Hanmis efocipegtrutide (HM15211), is in a phase 1 trial for weight loss and in a phase 1b/2a for nonalcoholic fatty liver disease (NAFLD)

doi: 10.1038/s41366-019-0513-y 47 ShettyRBasheerFTPoojariPGThungaGChandranVPAcharyaLD

Other common symptoms include diarrhea, fever, and chills